QIAGEN N.V. | 44.29 / -1.25% |
Date/Time | 01/25 / 17:29 |
Chg. / Chg.(%) | -0.56 / -1.25% |
Bid | 26.00 / 1174 |
Ask | 53.60 / 42 |
Open | 44.98 |
Previous Close | 44.85 |
High | 45.39 |
Low | 44.01 |
Volume [EUR] | 12,257,953.51 |
Volume [Units] | 273,313 |
Price fixings | 959 |
ISIN | NL0012169213 |
Security | QIA/D |
Exchange | Turquoise |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NYSE | 53.85 | ![]() |
523,466 |
Xetra | 44.370 | ![]() |
470,735 |
Turquoise | 44.29 | ![]() |
273,313 |
Cboe Europe .. | 44.37 | ![]() |
248,920 |
London Inter.. | 44.29 | ![]() |
58,480 |
TradeGate | 44.36 | ![]() |
21,553 |
Cboe US | 53.84 | ![]() |
18,435 |
Hannover | 44.450 | ![]() |
7,311 |
Frankfurt | 44.1700 | ![]() |
6,803 |
IEX | 53.83 | ![]() |
4,996 |
gettex | 44.480 | ![]() |
2,494 |
Stuttgart | 44.390 | ![]() |
1,683 |
München | 44.640 | ![]() |
515 |
Cboe Europe .. | 44.06 | ![]() |
56 |
Cboe Europe .. | 44.55 | ![]() |
38 |
Vienna Globa.. | 44.27 | ![]() |
0 |
Düsseldorf | 44.160 | ![]() |
0 |
Hamburg | 44.840 | ![]() |
0 |
Berlin | 44.800 | ![]() |
0 |
Lang & Schwa.. | 44.380 | ![]() |
|
EUREX | Options |
News
- OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire